Parties Debate H.R. 3’s Impact On Patients; GOP Pilots China Argument

By John Wilkerson / May 4, 2021 at 7:09 PM
The two parties argued for four hours Tuesday (May 4) over whether Medicare drug price negotiation and international reference pricing would help or hurt patients, and Republicans brought up new arguments against the policies, including that they would play into the hands of China and that coronavirus vaccines might not have been invented if Democrats’ drug pricing bill, H.R. 3, were law. Democrats held the hearing to build support for H.R. 3 after the president excluded it from his American...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.